Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here’s Why That’s a Smart Move.
Hot off the approval of its gene therapy for a pair of rare hereditary blood disorders, Vertex Pharmaceuticals (VRTX -0.96%)
Read MoreHot off the approval of its gene therapy for a pair of rare hereditary blood disorders, Vertex Pharmaceuticals (VRTX -0.96%)
Read MoreYou may want to take February 21, 2024 off from work. Why? The most important company in all of humanity,
Read MoreElgin’s strategy to revitalize downtown has been geared toward attracting visitors from outside the city, but a new market analysis
Read MoreSalesforce’s (CRM) stock was up more than 2% on Wednesday after launching a new artificial intelligence focused product on Slack.
Read MoreFruit for sale at the Love, Linda Vista Farmers Market. Image from the market’s Facebook page The non-profit Love, Linda
Read MoreShare: Canadian Dollar sees thin gains with support from steady Crude Oil bids. Canada sees a data-light economic calendar this
Read MoreLayer-2 token Immutable X (IMX), decentralized finance Pendle (PENDLE), and Solana’s dog-themed coin Bonk (BONK) were the best performers among
Read MoreThe Wall Street Journal reports OpenAI CEO Sam Altman is hot on the fundraising trail, courting governments in the Middle
Read MoreJeffrey Sprecher, chair and chief executive of ICE, said the growth of its Brent suite of contracts provides a blueprint
Read MoreEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time
Read More